Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty
Liposomal Bupivacaine vs. Interscalene Nerve Block for Pain Control After Total Shoulder Arthroplasty: A Randomized Clinical Trial
Sponsor: Johns Hopkins University
A NA clinical study on Arthropathy and Closed Fracture Proximal Humerus, Four Part, this trial is completed. The trial is conducted by Johns Hopkins University and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
-
Jan 2020 — Apr 2020 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2019 — Jan 2020 [monthly]
Recruiting NA
-
Jan 2019 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Dec 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins University
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .